In addition, GBMs expressing high CD44 in the tumor periphery show enhanced expression of CD44 by inhibition of VEGF with Bev, leading to more invasive and aggressive tumors, and resulting in earlier progression and worse prognosis. Here, CD44 is linked to neoplasm.